Topical corticosteroids for vitiligo

Vitiligo causes areas of skin to lose pigment when pigment-making cells are affected. A topical corticosteroid may be considered to calm immune activity around an active patch and support pigment return in selected cases. It does not restore pigment in every person, and visible change can take time.

The face and body may need different treatment plans because skin thickness and sensitivity vary. A dermatologist may consider the location, size, activity of the patches, age, and skin history before choosing a medicine. New white patches also deserve assessment so the diagnosis is clear.

Apply only the prescribed product to the intended patches and follow the review plan. Do not increase the amount or cover the area to speed results. Protect depigmented skin from sun exposure with shade, clothing, and a suitable sunscreen because it burns more readily and the contrast may become more noticeable.

Use bland moisturiser if the area is dry and avoid irritating cosmetic or bleaching products. Take progress photographs only if your clinician finds them useful, using similar lighting and positioning so changes are easier to judge.

Arrange review if new patches appear, existing areas expand, or the treated skin becomes thin, sore, or unusually red. Seek prompt care for pus, increasing warmth, fever, or rapidly worsening pain. Urgent help is needed for facial swelling, breathing difficulty, or a severe widespread reaction after application.

Ask whether your vitiligo is active, which sites are suitable for this medicine, how long a trial should last, and what alternatives exist if pigment does not return. Discuss sun protection, monitoring for skin changes, and whether other affected areas need a separate plan.